| All cases (N = 353) | ||
---|---|---|---|
 | Amikacin (n = 51) | Kanamycin (n = 302) | P- value |
Age (years): mean ± SD | 35.69 ± 9.56 | 36.47 ± 11.57 | P = 0.85 |
Body weight (kgs): mean ± SD | 49.58 ± 8.83 | 50.76 ± 12.0 | P = 0.77 |
Sex: | Â | Â | Â |
 Male, n (%) | 32 (63 %) | 166 (55 %) | P = 0.47 |
 Female, n (%) | 19 (37 % | 136 (45 %) |  |
HIV co-infection: n (%) | 25 (49 %) | 139 (46 %) | P = 0.53 |
DR-TB site: | Â | Â | Â |
 Katutura | 0 | 46 (15 %) |  |
 Oshakati | 1 (2 %) | 65 (22 %) | P < 0.001 |
 Rundu | 0 | 67 (22 %) |  |
 Walvis Bay | 50 (98 %) | 124 (41 %) |  |
Reporting period: | Â | Â | Â |
 2004–2009, n (%) | 45 (88 %) | 48 (16 %) | P < 0.001 |
 2010–2011, n (%) | 4 (8 %) | 61 (20 %) |  |
 2012, n (%) | 1 (2 %) | 112 (37 %) |  |
 2013–2014, n (%) | 0 | 80 (27 %) |  |
 Missing, n (%) | 1 (2 %) | 1 (0.3 %) |  |